{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T02:10:48Z","timestamp":1783649448083,"version":"3.55.0"},"reference-count":142,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T00:00:00Z","timestamp":1733788800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ginseng Research"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jgr.2024.12.004","type":"journal-article","created":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T07:41:28Z","timestamp":1733816488000},"page":"105-117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Antiviral potential of ginseng: Targeting human pathogenic viruses with compounds derived from ginseng"],"prefix":"10.1016","volume":"49","author":[{"given":"Chen","family":"Huo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7085-6399","authenticated-orcid":false,"given":"Jihye","family":"Baek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5285-9138","authenticated-orcid":false,"given":"Ki Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgr.2024.12.004_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2021.113112","article-title":"Electrochemical diagnostics of infectious viral diseases: trends and challenges","volume":"180","author":"Goud","year":"2021","journal-title":"Biosens Bioelectron"},{"key":"10.1016\/j.jgr.2024.12.004_bib2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.virusres.2014.09.011","article-title":"Human coronaviruses: viral and cellular factors involved in neuroinvasiveness and neuropathogenesis","volume":"194","author":"Desforges","year":"2014","journal-title":"Virus Res"},{"issue":"1","key":"10.1016\/j.jgr.2024.12.004_bib3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1749-6632.2009.04993.x","article-title":"The great billion\u2010year war between ribosome\u2010and capsid\u2010encoding organisms (cells and viruses) as the major source of evolutionary novelties","volume":"1178","author":"Forterre","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jgr.2024.12.004_bib4","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.virol.2015.02.039","article-title":"Origins and evolution of viruses of eukaryotes: the ultimate modularity","volume":"479","author":"Koonin","year":"2015","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.jgr.2024.12.004_bib5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2174\/1389450119666190920153247","article-title":"Antiviral drug targets of single-stranded RNA viruses causing chronic human diseases","volume":"21","author":"Dinesh","year":"2020","journal-title":"Curr Drug Targets"},{"issue":"3","key":"10.1016\/j.jgr.2024.12.004_bib6","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/s41591-021-01282-0","article-title":"Developing therapeutic approaches for twenty-first-century emerging infectious viral diseases","volume":"27","author":"Meganck","year":"2021","journal-title":"Nat Med"},{"issue":"9","key":"10.1016\/j.jgr.2024.12.004_bib7","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.3390\/nu12092879","article-title":"Immune modulatory effects of vitamin D on viral infections","volume":"12","author":"Siddiqui","year":"2020","journal-title":"Nutrients"},{"issue":"7","key":"10.1016\/j.jgr.2024.12.004_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28950","article-title":"Advances in HPV\u2010associated tumor management: therapeutic strategies and emerging insights","volume":"95","author":"Gong","year":"2023","journal-title":"J Med Virol"},{"key":"10.1016\/j.jgr.2024.12.004_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.732891","article-title":"A review of medicinal plants with antiviral activity available in Bangladesh and mechanistic insight into their bioactive metabolites on SARS-CoV-2, HIV and HBV","volume":"12","author":"Bachar","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jgr.2024.12.004_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.sintl.2020.100042","article-title":"Global impacts of pre-and post-COVID-19 pandemic: focus on socio-economic consequences","volume":"1","author":"Mishra","year":"2020","journal-title":"Sensors International"},{"issue":"2","key":"10.1016\/j.jgr.2024.12.004_bib11","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41577-020-00479-7","article-title":"A guide to vaccinology: from basic principles to new developments","volume":"21","author":"Pollard","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jgr.2024.12.004_bib12","doi-asserted-by":"crossref","DOI":"10.1177\/20587384211002621","article-title":"A review: mechanism of action of antiviral drugs","volume":"35","author":"Kausar","year":"2021","journal-title":"International journal of immunopathology and pharmacology"},{"issue":"16","key":"10.1016\/j.jgr.2024.12.004_bib13","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1001\/jama.2020.17025","article-title":"Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2020 recommendations of the International Antiviral Society\u2013USA Panel","volume":"324","author":"Saag","year":"2020","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.jgr.2024.12.004_bib14","doi-asserted-by":"crossref","first-page":"e428","DOI":"10.1016\/S2665-9913(20)30120-X","article-title":"The immunology of COVID-19: is immune modulation an option for treatment?","volume":"2","author":"Zhong","year":"2020","journal-title":"The Lancet Rheumatology"},{"issue":"1","key":"10.1016\/j.jgr.2024.12.004_bib15","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1021\/acsnano.9b03978","article-title":"Stromal modulation and treatment of metastatic pancreatic cancer with local intraperitoneal triple miRNA\/siRNA nanotherapy","volume":"14","author":"Xie","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.jgr.2024.12.004_bib16","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.coviro.2021.04.006","article-title":"Considerations for the discovery and development of 3-chymotrypsin-like cysteine protease inhibitors targeting SARS-CoV-2 infection","volume":"49","author":"Vandyck","year":"2021","journal-title":"Current Opinion in Virology"},{"issue":"8","key":"10.1016\/j.jgr.2024.12.004_bib17","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.3390\/molecules25081800","article-title":"Natural bioactive compounds from fungi as potential candidates for protease inhibitors and immunomodulators to apply for coronaviruses","volume":"25","author":"Suwannarach","year":"2020","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.jgr.2024.12.004_bib18","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/path.1896","article-title":"Viral gene therapy strategies: from basic science to clinical application","volume":"208","author":"Young","year":"2006","journal-title":"J Pathol: A Journal of the Pathological Society of Great Britain and Ireland"},{"issue":"1","key":"10.1016\/j.jgr.2024.12.004_bib19","first-page":"14","article-title":"Viral infectious disease and natural products with antiviral activity","volume":"1","author":"Kitazato","year":"2007","journal-title":"Drug Discov Ther"},{"issue":"5","key":"10.1016\/j.jgr.2024.12.004_bib20","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.nbt.2009.03.007","article-title":"Recent advancements for the evaluation of anti-viral activities of natural products","volume":"25","author":"Chattopadhyay","year":"2009","journal-title":"New Biotechnology"},{"issue":"5","key":"10.1016\/j.jgr.2024.12.004_bib21","doi-asserted-by":"crossref","first-page":"828","DOI":"10.3390\/v13050828","article-title":"Antiviral activity exerted by natural products against human viruses","volume":"13","author":"Musarra-Pizzo","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.jgr.2024.12.004_bib22","article-title":"Emerging paradigms of viral diseases and paramount role of natural resources as antiviral agents","volume":"759","author":"Jansi","year":"2021","journal-title":"Sci Total Environ"},{"key":"10.1016\/j.jgr.2024.12.004_bib23","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s13337-020-00598-8","article-title":"Structure-based drug designing for potential antiviral activity of selected natural products from Ayurveda against SARS-CoV-2 spike glycoprotein and its cellular receptor","volume":"31","author":"Maurya","year":"2020","journal-title":"Virusdisease"},{"issue":"7","key":"10.1016\/j.jgr.2024.12.004_bib24","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/ptr.2384","article-title":"A comparison of the ancient use of ginseng in traditional Chinese medicine with modern pharmacological experiments and clinical trials","volume":"22","author":"Xiang","year":"2008","journal-title":"Phytother Res"},{"key":"10.1016\/j.jgr.2024.12.004_bib25","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s13596-016-0246-6","article-title":"Ginseng: a miracle sources of herbal and pharmacological uses","volume":"16","author":"Kim","year":"2016","journal-title":"Oriental Pharmacy and Experimental Medicine"},{"issue":"3","key":"10.1016\/j.jgr.2024.12.004_bib26","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1254\/jphs.CRJ05010X","article-title":"Use of ginseng in medicine with emphasis on neurodegenerative disorders","volume":"100","author":"Radad","year":"2006","journal-title":"Journal of pharmacological sciences"},{"issue":"4a","key":"10.1016\/j.jgr.2024.12.004_bib27","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1017\/S1368980000000550","article-title":"Efficacy and safety of ginseng","volume":"3","author":"Kitts","year":"2000","journal-title":"Publ Health Nutr"},{"issue":"10","key":"10.1016\/j.jgr.2024.12.004_bib28","first-page":"213","article-title":"A review of ginseng species in different regions as a multipurpose herb in traditional Chinese medicine, modern herbology and pharmacological science","volume":"13","author":"Shahrajabian","year":"2019","journal-title":"J Med Plants Res"},{"key":"10.1016\/j.jgr.2024.12.004_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.112792","article-title":"Traditional uses, chemical diversity and biological activities of Panax L.(Araliaceae): a review","volume":"263","author":"Liu","year":"2020","journal-title":"J Ethnopharmacol"},{"issue":"3","key":"10.1016\/j.jgr.2024.12.004_bib30","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jgr.2014.03.001","article-title":"A review on the medicinal potentials of ginseng and ginsenosides on cardiovascular diseases","volume":"38","author":"Lee","year":"2014","journal-title":"Journal of ginseng research"},{"issue":"1","key":"10.1016\/j.jgr.2024.12.004_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5142\/jgr.2012.36.1.1","article-title":"Chemical diversity of Panax ginseng, Panax quinquifolium, and Panax notoginseng","volume":"36","author":"Kim","year":"2012","journal-title":"Journal of ginseng research"},{"key":"10.1016\/j.jgr.2024.12.004_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105263","article-title":"Chemical constituents of Panax ginseng and Panax notoginseng explain why they differ in therapeutic efficacy","volume":"161","author":"Liu","year":"2020","journal-title":"Pharmacol Res"},{"issue":"4","key":"10.1016\/j.jgr.2024.12.004_bib33","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jgr.2020.01.005","article-title":"Physiological and pharmacological features of the non-saponin components in Korean Red Ginseng","volume":"44","author":"Hyun","year":"2020","journal-title":"Journal of Ginseng Research"},{"issue":"2","key":"10.1016\/j.jgr.2024.12.004_bib34","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jgr.2020.02.004","article-title":"Pharmacological potential of ginseng and its major component ginsenosides","volume":"45","author":"Ratan","year":"2021","journal-title":"Journal of ginseng research"},{"issue":"5","key":"10.1016\/j.jgr.2024.12.004_bib35","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1080\/10408398.2021.1952159","article-title":"Phytochemistry of ginsenosides: recent advancements and emerging roles","volume":"63","author":"Chopra","year":"2023","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"1","key":"10.1016\/j.jgr.2024.12.004_bib36","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jgr.2021.05.009","article-title":"Ginseng extract and ginsenosides improve neurological function and promote antioxidant effects in rats with spinal cord injury: a meta-analysis and systematic review","volume":"46","author":"Sng","year":"2022","journal-title":"Journal of Ginseng Research"},{"key":"10.1016\/j.jgr.2024.12.004_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110915","article-title":"Ginsenosides for the treatment of metabolic syndrome and cardiovascular diseases: pharmacology and mechanisms","volume":"132","author":"Fan","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jgr.2024.12.004_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/8985179","article-title":"Chemical composition, biological activity, and health-promoting effects of withania somnifera for pharma-food industry applications","volume":"2021","author":"Sharifi-Rad","year":"2021","journal-title":"J Food Qual"},{"issue":"24","key":"10.1016\/j.jgr.2024.12.004_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242417290","article-title":"Therapeutic applications of ginseng natural compounds for health management","volume":"24","author":"Ahmad","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.jgr.2024.12.004_bib40","doi-asserted-by":"crossref","first-page":"8","DOI":"10.5142\/jgr.2013.37.8","article-title":"A comprehensive review of the therapeutic and pharmacological effects of ginseng and ginsenosides in central nervous system","volume":"37","author":"Kim","year":"2013","journal-title":"Journal of ginseng research"},{"issue":"3","key":"10.1016\/j.jgr.2024.12.004_bib41","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jgr.2017.10.004","article-title":"Pharmacological and medical applications of Panax ginseng and ginsenosides: a review for use in cardiovascular diseases","volume":"42","author":"Kim","year":"2018","journal-title":"Journal of ginseng research"},{"key":"10.1016\/j.jgr.2024.12.004_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153717","article-title":"A comprehensive review on the phytochemistry, pharmacokinetics, and antidiabetic effect of Ginseng","volume":"92","author":"Liu","year":"2021","journal-title":"Phytomedicine"},{"issue":"8","key":"10.1016\/j.jgr.2024.12.004_bib43","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1128\/CVI.00013-09","article-title":"Beneficial effects of a combination of Korean red ginseng and highly active antiretroviral therapy in human immunodeficiency virus type 1-infected patients","volume":"16","author":"Sung","year":"2009","journal-title":"Clin Vaccine Immunol"},{"issue":"4","key":"10.1016\/j.jgr.2024.12.004_bib44","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jgr.2015.09.002","article-title":"Ginseng, the natural effectual antiviral: protective effects of Korean Red Ginseng against viral infection","volume":"40","author":"Im","year":"2016","journal-title":"Journal of ginseng research"},{"issue":"1","key":"10.1016\/j.jgr.2024.12.004_bib45","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1128\/CMR.00077-12","article-title":"Human rhinoviruses","volume":"26","author":"Jacobs","year":"2013","journal-title":"Clin Microbiol Rev"},{"issue":"12","key":"10.1016\/j.jgr.2024.12.004_bib46","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1073\/pnas.42.12.892","article-title":"The isolation of a new virus associated with respiratory clinical disease in humans","volume":"42","author":"Price","year":"1956","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jgr.2024.12.004_bib47","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.3389\/fmicb.2017.02412","article-title":"Rhinovirus biology, antigenic diversity, and advancements in the design of a human rhinovirus vaccine","volume":"8","author":"Stobart","year":"2017","journal-title":"Front Microbiol"},{"issue":"13","key":"10.1016\/j.jgr.2024.12.004_bib48","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.3390\/molecules26134095","article-title":"Pharmacological efficacy of ginseng against respiratory tract infections","volume":"26","author":"Alsayari","year":"2021","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.jgr.2024.12.004_bib49","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1378\/chest.13-1567","article-title":"Airway inflammation and illness severity in response to experimental rhinovirus infection in asthma","volume":"145","author":"Zhu","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.jgr.2024.12.004_bib50","first-page":"1567","article-title":"Korean red ginseng attenuates rhinovirus-stimulated IL-8, IL-6 responses in human nasal epithelial cells","volume":"10","author":"Kim","year":"2017","journal-title":"Int J Clin Exp Med"},{"issue":"3","key":"10.1016\/j.jgr.2024.12.004_bib51","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jgr.2014.04.003","article-title":"Antiviral activity of ginsenosides against coxsackievirus B3, enterovirus 71, and human rhinovirus 3","volume":"38","author":"Song","year":"2014","journal-title":"Journal of ginseng research"},{"issue":"5","key":"10.1016\/j.jgr.2024.12.004_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e27688","article-title":"Ginsenoside Re protects rhinovirus-induced disruption of tight junction through inhibition of ROS-mediated phosphatases inactivation in human nasal epithelial cells","volume":"10","author":"Kim","year":"2024","journal-title":"Heliyon"},{"issue":"8","key":"10.1016\/j.jgr.2024.12.004_bib53","doi-asserted-by":"crossref","first-page":"4638","DOI":"10.1002\/jmv.26990","article-title":"A brief review of influenza virus infection","volume":"93","author":"Javanian","year":"2021","journal-title":"J Med Virol"},{"key":"10.1016\/j.jgr.2024.12.004_bib54","series-title":"Seminars in respiratory and critical care medicine","article-title":"Human influenza virus infections","year":"2016"},{"issue":"2","key":"10.1016\/j.jgr.2024.12.004_bib55","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.virol.2010.12.003","article-title":"Influenza virus assembly and budding","volume":"411","author":"Rossman","year":"2011","journal-title":"Virology"},{"issue":"5","key":"10.1016\/j.jgr.2024.12.004_bib56","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nri3665","article-title":"Innate immunity to influenza virus infection","volume":"14","author":"Iwasaki","year":"2014","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"10.1016\/j.jgr.2024.12.004_bib57","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.tim.2022.09.015","article-title":"A structural understanding of influenza virus genome replication","volume":"31","author":"Zhu","year":"2023","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.jgr.2024.12.004_bib58","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s40011-011-0009-6","article-title":"Influenza virus: a brief overview","volume":"82","author":"Dangi","year":"2012","journal-title":"Proc Natl Acad Sci India B Biol Sci"},{"key":"10.1016\/j.jgr.2024.12.004_bib59","series-title":"Overview of influenza viruses","first-page":"1","author":"Pleschka","year":"2012"},{"issue":"6088","key":"10.1016\/j.jgr.2024.12.004_bib60","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1126\/science.1213362","article-title":"Airborne transmission of influenza A\/H5N1 virus between ferrets","volume":"336","author":"Herfst","year":"2012","journal-title":"science"},{"key":"10.1016\/j.jgr.2024.12.004_bib61","article-title":"Influenza A virus transmission: contributing factors and clinical implications","volume":"12","author":"Belser","year":"2010","journal-title":"Expet Rev Mol Med"},{"key":"10.1016\/j.jgr.2024.12.004_bib62","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s00239-008-9119-z","article-title":"The evolutionary dynamics of human influenza B virus","volume":"66","author":"Chen","year":"2008","journal-title":"J Mol Evol"},{"issue":"3","key":"10.1016\/j.jgr.2024.12.004_bib63","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1248\/bpb.28.399","article-title":"Sialobiology of influenza: molecular mechanism of host range variation of influenza viruses","volume":"28","author":"Suzuki","year":"2005","journal-title":"Biol Pharm Bull"},{"issue":"9","key":"10.1016\/j.jgr.2024.12.004_bib64","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3390\/v10090471","article-title":"Antiviral activity of fermented ginseng extracts against a broad range of influenza viruses","volume":"10","author":"Wang","year":"2018","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.jgr.2024.12.004_bib65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171936","article-title":"Inhibition of influenza A virus infection by ginsenosides","volume":"12","author":"Dong","year":"2017","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jgr.2024.12.004_bib66","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.intimp.2009.12.009","article-title":"Enhancement of immune responses to influenza vaccine (H3N2) by ginsenoside Re","volume":"10","author":"Song","year":"2010","journal-title":"Int Immunopharm"},{"key":"10.1016\/j.jgr.2024.12.004_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.764297","article-title":"A herbal mixture formula of OCD20015-V009 prophylactic administration to enhance interferon-mediated antiviral activity against influenza A virus","volume":"12","author":"Kwon","year":"2021","journal-title":"Front Pharmacol"},{"issue":"5","key":"10.1016\/j.jgr.2024.12.004_bib68","doi-asserted-by":"crossref","first-page":"4967","DOI":"10.3390\/ijms24054967","article-title":"Antiviral effect of ginsenosides Rk1 against influenza a virus infection by targeting the hemagglutinin 1-mediated virus attachment","volume":"24","author":"Yang","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10.1016\/j.jgr.2024.12.004_bib69","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1089\/jmf.2012.0017","article-title":"Protective effect of Korean red ginseng extract on the infections by H1N1 and H3N2 influenza viruses in mice","volume":"15","author":"Yoo","year":"2012","journal-title":"J Med Food"},{"issue":"5","key":"10.1016\/j.jgr.2024.12.004_bib70","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJM199302043280508","article-title":"The immunopathogenesis of human immunodeficiency virus infection","volume":"328","author":"Pantaleo","year":"1993","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jgr.2024.12.004_bib71","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000445852","article-title":"Human immunodeficiency virus (HIV)","volume":"43","author":"Blood","year":"2016","journal-title":"Transfus Med Hemotherapy"},{"issue":"37","key":"10.1016\/j.jgr.2024.12.004_bib72","doi-asserted-by":"crossref","first-page":"6191","DOI":"10.1016\/j.vaccine.2011.06.085","article-title":"Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: a review","volume":"29","author":"Girard","year":"2011","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.jgr.2024.12.004_bib73","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/imr.12066","article-title":"CD 4+ T\u2010cell depletion in HIV infection: mechanisms of immunological failure","volume":"254","author":"Okoye","year":"2013","journal-title":"Immunol Rev"},{"issue":"1","key":"10.1016\/j.jgr.2024.12.004_bib74","doi-asserted-by":"crossref","DOI":"10.24875\/AIDSRev.M20000029","article-title":"Antiretroviral therapy for HIV-2 infection in non-endemic regions","volume":"22","author":"de Mendoza","year":"2020","journal-title":"AIDS Rev"},{"issue":"6","key":"10.1016\/j.jgr.2024.12.004_bib75","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1128\/AAC.46.6.1896-1905.2002","article-title":"Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy","volume":"46","author":"Wei","year":"2002","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"3","key":"10.1016\/j.jgr.2024.12.004_bib76","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0166-3542(98)00025-4","article-title":"The role of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infection","volume":"38","author":"De Clercq","year":"1998","journal-title":"Antivir Res"},{"issue":"3_suppl","key":"10.1016\/j.jgr.2024.12.004_bib77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/135965350100603S01","article-title":"An introduction to nucleoside and nucleotide analogues","volume":"6","author":"Squires","year":"2001","journal-title":"Antivir Ther"},{"issue":"4","key":"10.1016\/j.jgr.2024.12.004_bib78","doi-asserted-by":"crossref","first-page":"173","DOI":"10.5142\/JGR.2004.28.4.173","article-title":"Korean red ginseng significantly slows CD4 T cell depletion over 10 years in HIV-1 infected patients: association with HLA","volume":"28","author":"Cho","year":"2004","journal-title":"Journal of Ginseng Research"},{"issue":"4","key":"10.1016\/j.jgr.2024.12.004_bib79","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1128\/CDLI.12.4.497-501.2005","article-title":"Korean red ginseng slows depletion of CD4 T cells in human immunodeficiency virus type 1-infected patients","volume":"12","author":"Sung","year":"2005","journal-title":"Clin Vaccine Immunol"},{"issue":"6","key":"10.1016\/j.jgr.2024.12.004_bib80","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0040-4039(01)02310-3","article-title":"Polyacetyleneginsenoside-Ro, a novel triterpene saponin from Panax ginseng","volume":"43","author":"Zhang","year":"2002","journal-title":"Tetrahedron Lett"},{"issue":"2","key":"10.1016\/j.jgr.2024.12.004_bib81","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.phytol.2008.12.001","article-title":"Anti-HIV protease triterpenoids from the acid hydrolysate of Panax ginseng","volume":"2","author":"Wei","year":"2009","journal-title":"Phytochem Lett"},{"issue":"7","key":"10.1016\/j.jgr.2024.12.004_bib82","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021781","article-title":"Novel PI3K\/Akt inhibitors screened by the cytoprotective function of human immunodeficiency virus type 1 Tat","volume":"6","author":"Kim","year":"2011","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.jgr.2024.12.004_bib83","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1248\/bpb.b13-00013","article-title":"Ginsenoside Rh1 eliminates the cytoprotective phenotype of human immunodeficiency virus type 1-transduced human macrophages by inhibiting the phosphorylation of pyruvate dehydrogenase lipoamide kinase isozyme 1","volume":"36","author":"Jeong","year":"2013","journal-title":"Biol Pharm Bull"},{"issue":"8","key":"10.1016\/j.jgr.2024.12.004_bib84","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1089\/jmf.2013.3020","article-title":"Ginsenoside Rb1 eliminates HIV-1 (D3)-transduced cytoprotective human macrophages by inhibiting the AKT pathway","volume":"17","author":"Jeong","year":"2014","journal-title":"J Med Food"},{"issue":"4","key":"10.1016\/j.jgr.2024.12.004_bib85","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1002\/hep.26901","article-title":"The ABCs of viral hepatitis that define biomarker signatures of acute viral hepatitis","volume":"59","author":"Duffy","year":"2014","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.jgr.2024.12.004_bib86","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1159\/000046265","article-title":"Long-term impact of hepatitis B, C virus infection on renal transplantation","volume":"21","author":"Lee","year":"2001","journal-title":"Am J Nephrol"},{"issue":"7279","key":"10.1016\/j.jgr.2024.12.004_bib87","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1136\/bmj.322.7279.151","article-title":"Acute hepatitis","volume":"322","author":"Ryder","year":"2001","journal-title":"Bmj"},{"key":"10.1016\/j.jgr.2024.12.004_bib88","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.meegid.2013.10.023","article-title":"Hepatitis A virus: host interactions, molecular epidemiology and evolution","volume":"21","author":"Vaughan","year":"2014","journal-title":"Infect Genet Evol"},{"issue":"1","key":"10.1016\/j.jgr.2024.12.004_bib89","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41572-023-00461-2","article-title":"Hepatitis A virus infection","volume":"9","author":"Van Damme","year":"2023","journal-title":"Nat Rev Dis Prim"},{"issue":"2","key":"10.1016\/j.jgr.2024.12.004_bib90","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/oxfordjournals.aje.a114093","article-title":"Frequency of illness associated with epidemic hepatitis A virus infections in adults","volume":"122","author":"Lednar","year":"1985","journal-title":"American journal of epidemiology"},{"issue":"21","key":"10.1016\/j.jgr.2024.12.004_bib91","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.clinmicnews.2020.10.001","article-title":"Hepatitis A and Hepatitis E: clinical and epidemiological features, diagnosis, treatment, and prevention","volume":"42","author":"Webb","year":"2020","journal-title":"Clin Microbiol Newsl"},{"key":"10.1016\/j.jgr.2024.12.004_bib92","article-title":"Transmission, pathology, and prevention strategies of hepatitis A virus","volume":"14","author":"Li","year":"2023","journal-title":"Mol Pathog"},{"key":"10.1016\/j.jgr.2024.12.004_bib93","doi-asserted-by":"crossref","first-page":"147","DOI":"10.62480\/tjms.2023.vol26.pp147-150","article-title":"Hepatitis-induced hemolysis in pediatrics: a rare case report","volume":"26","author":"Laylani","year":"2023","journal-title":"Texas Journal of Medical Science"},{"issue":"5","key":"10.1016\/j.jgr.2024.12.004_bib94","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1080\/21645515.2020.1819742","article-title":"Hepatitis A vaccination and its immunological and epidemiological long-term effects\u2013a review of the evidence","volume":"17","author":"Herzog","year":"2021","journal-title":"Hum Vaccines Immunother"},{"issue":"3","key":"10.1016\/j.jgr.2024.12.004_bib95","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4254\/wjh.v4.i3.68","article-title":"Hepatitis A: epidemiology and prevention in developing countries","volume":"4","author":"Franco","year":"2012","journal-title":"World J Hepatol"},{"issue":"9","key":"10.1016\/j.jgr.2024.12.004_bib96","doi-asserted-by":"crossref","first-page":"M1412","DOI":"10.1111\/1750-3841.12205","article-title":"Reduction of hepatitis A virus on FRhK\u20104 cells treated with Korean red ginseng extract and ginsenosides","volume":"78","author":"Lee","year":"2013","journal-title":"Journal of food science"},{"issue":"3","key":"10.1016\/j.jgr.2024.12.004_bib97","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jhep.2014.04.026","article-title":"The role of Kupffer cells in hepatitis B and hepatitis C virus infections","volume":"61","author":"Boltjes","year":"2014","journal-title":"Journal of hepatology"},{"issue":"1","key":"10.1016\/j.jgr.2024.12.004_bib98","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/hep.21902","article-title":"Acute hepatitis C virus infection: a chronic problem","volume":"47","author":"Blackard","year":"2008","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jgr.2024.12.004_bib99","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.clim.2009.10.007","article-title":"HCV-related hepatocellular carcinoma: from chronic inflammation to cancer","volume":"134","author":"Castello","year":"2010","journal-title":"Clin Immunol"},{"issue":"11","key":"10.1016\/j.jgr.2024.12.004_bib100","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1016\/j.biocel.2013.08.016","article-title":"Stimulation of TRAF6\/TAK1 degradation and inhibition of JNK\/AP-1 signalling by ginsenoside Rg3 attenuates hepatitis B virus replication","volume":"45","author":"Kang","year":"2013","journal-title":"Int J Biochem Cell Biol"},{"issue":"3","key":"10.1016\/j.jgr.2024.12.004_bib101","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/hep.29177","article-title":"Ginsenoside Rg3 restores hepatitis C virus\u2013induced aberrant mitochondrial dynamics and inhibits virus propagation","volume":"66","author":"Kim","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jgr.2024.12.004_bib102","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.617578","article-title":"Herpes simplex virus cell entry mechanisms: an update","volume":"10","author":"Madavaraju","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jgr.2024.12.004_bib103","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3389\/fmicb.2020.00139","article-title":"Current antivirals and novel botanical molecules interfering with herpes simplex virus infection","volume":"11","author":"\u00c1lvarez","year":"2020","journal-title":"Front Microbiol"},{"issue":"6 Suppl 1","key":"10.1016\/j.jgr.2024.12.004_bib104","first-page":"S11","article-title":"Guideline for the management herpes simplex 1 and cosmetic interventions","volume":"14","author":"Vaghela","year":"2021","journal-title":"The Journal of clinical and aesthetic dermatology"},{"issue":"1","key":"10.1016\/j.jgr.2024.12.004_bib105","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jpag.2021.07.001","article-title":"Adolescent primary genital herpes simplex virus type 1 infection with sepsis secondary to streptococcus pyogenes Bacteremia","volume":"35","author":"Holt","year":"2022","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"8","key":"10.1016\/j.jgr.2024.12.004_bib106","first-page":"758","article-title":"Genital herpes in human immunodeficiency virus infected patients","volume":"5","author":"Sunur","year":"2021","journal-title":"Bioscientia Medicina: Journal of Biomedicine and Translational Research"},{"issue":"2","key":"10.1016\/j.jgr.2024.12.004_bib107","doi-asserted-by":"crossref","first-page":"210","DOI":"10.5142\/jgr.2013.37.210","article-title":"Protective effects of red ginseng extract against vaginal herpes simplex virus infection","volume":"37","author":"Cho","year":"2013","journal-title":"Journal of Ginseng Research"},{"key":"10.1016\/j.jgr.2024.12.004_bib108","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s12250-012-3220-6","article-title":"Inhibitory effects of Ginsenoside Rb1 on apoptosis caused by HSV-1 in human glioma cells","volume":"27","author":"Liang","year":"2012","journal-title":"Virol Sin"},{"issue":"1","key":"10.1016\/j.jgr.2024.12.004_bib109","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4014\/jmb.1908.08047","article-title":"Inhibition of herpes simplex viruses, types 1 and 2, by ginsenoside 20 (S)-Rg3","volume":"30","author":"Wright","year":"2020","journal-title":"J Microbiol Biotechnol"},{"key":"10.1016\/j.jgr.2024.12.004_bib110","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jff.2017.11.011","article-title":"Antiviral activity of ginsenoside Rg3 isomers against gammaherpesvirus through inhibition of p38-and JNK-associated pathways","volume":"40","author":"Kang","year":"2018","journal-title":"J Funct Foods"},{"issue":"4","key":"10.1016\/j.jgr.2024.12.004_bib111","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.jgr.2016.08.010","article-title":"Antiviral activity of 20 (R)-ginsenoside Rh2 against murine gammaherpesvirus","volume":"41","author":"Kang","year":"2017","journal-title":"Journal of ginseng research"},{"issue":"4","key":"10.1016\/j.jgr.2024.12.004_bib112","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jgr.2024.01.006","article-title":"Ginsenoside Rg5, a potent agonist of Nrf2, inhibits HSV-1 infection-induced neuroinflammation by inhibiting oxidative stress and NF-\u03baB activation","volume":"48","author":"Kim","year":"2024","journal-title":"Journal of Ginseng Research"},{"issue":"6","key":"10.1016\/j.jgr.2024.12.004_bib113","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/s41579-018-0005-4","article-title":"The life cycle of non-polio enteroviruses and how to target it","volume":"16","author":"Baggen","year":"2018","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jgr.2024.12.004_bib114","series-title":"Seminars in pediatric infectious diseases","article-title":"Enterovirus infections: diagnosis and treatment","year":"2002"},{"issue":"2","key":"10.1016\/j.jgr.2024.12.004_bib115","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jcv.2011.03.006","article-title":"An automated genotyping tool for enteroviruses and noroviruses","volume":"51","author":"Kroneman","year":"2011","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jgr.2024.12.004_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.113401","article-title":"Ginsenoside Rb1 is an immune-stimulatory agent with antiviral activity against enterovirus 71","volume":"266","author":"Kang","year":"2021","journal-title":"J Ethnopharmacol"},{"issue":"9","key":"10.1016\/j.jgr.2024.12.004_bib117","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s12265-015-9659-8","article-title":"Panax notoginseng saponins ameliorates coxsackievirus B3-induced myocarditis by activating the cystathionine-\u03b3-lyase\/hydrogen sulfide pathway","volume":"8","author":"Pan","year":"2015","journal-title":"Journal of cardiovascular translational research"},{"issue":"6","key":"10.1016\/j.jgr.2024.12.004_bib118","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1159\/000331229","article-title":"Protective effects of 20 (s)-protopanaxtriol on viral myocarditis infected by coxsackievirus B3","volume":"79","author":"Wang","year":"2012","journal-title":"Pathobiology"},{"issue":"6","key":"10.1016\/j.jgr.2024.12.004_bib119","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/etm.2023.12288","article-title":"A combination of Sophora flavescens alkaloids and Panax quinquefolium saponins attenuates coxsackievirus B3-induced acute myocarditis in mice via NF-\u03baB signaling","volume":"25","author":"Liu","year":"2023","journal-title":"Exp Ther Med"},{"issue":"4","key":"10.1016\/j.jgr.2024.12.004_bib120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151219","article-title":"Global economic burden of norovirus gastroenteritis","volume":"11","author":"Bartsch","year":"2016","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.jgr.2024.12.004_bib121","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1099\/jgv.0.001332","article-title":"ICTV virus taxonomy profile: Caliciviridae","volume":"100","author":"Vinj\u00e9","year":"2019","journal-title":"J Gen Virol"},{"issue":"2","key":"10.1016\/j.jgr.2024.12.004_bib122","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1128\/JCM.01535-14","article-title":"Advances in laboratory methods for detection and typing of norovirus","volume":"53","author":"Vinj\u00e9","year":"2015","journal-title":"J Clin Microbiol"},{"issue":"9","key":"10.1016\/j.jgr.2024.12.004_bib123","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1128\/JCM.00499-08","article-title":"Analysis of integrated virological and epidemiological reports of norovirus outbreaks collected within the Foodborne Viruses in Europe network from 1 July 2001 to 30 June 2006","volume":"46","author":"Kroneman","year":"2008","journal-title":"J Clin Microbiol"},{"issue":"7","key":"10.1016\/j.jgr.2024.12.004_bib124","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nrmicro.2016.48","article-title":"Human norovirus transmission and evolution in a changing world","volume":"14","author":"De Graaf","year":"2016","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"10.1016\/j.jgr.2024.12.004_bib125","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1128\/CMR.00075-14","article-title":"Norovirus","volume":"28","author":"Robilotti","year":"2015","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"10.1016\/j.jgr.2024.12.004_bib126","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1128\/AEM.02095-06","article-title":"Evaluation of murine norovirus, feline calicivirus, poliovirus, and MS2 as surrogates for human norovirus in a model of viral persistence in surface water and groundwater","volume":"74","author":"Bae","year":"2008","journal-title":"Appl Environ Microbiol"},{"issue":"4","key":"10.1016\/j.jgr.2024.12.004_bib127","doi-asserted-by":"crossref","first-page":"429","DOI":"10.5142\/jgr.2011.35.4.429","article-title":"Antiviral effect of Korean red ginseng extract and ginsenosides on murine norovirus and feline calicivirus as surrogates for human norovirus","volume":"35","author":"Lee","year":"2011","journal-title":"Journal of ginseng research"},{"issue":"14","key":"10.1016\/j.jgr.2024.12.004_bib128","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.3390\/diagnostics13142418","article-title":"Optical biosensors for the diagnosis of COVID-19 and other viruses\u2014a review","volume":"13","author":"John","year":"2023","journal-title":"Diagnostics"},{"issue":"11","key":"10.1016\/j.jgr.2024.12.004_bib129","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.jiph.2020.07.011","article-title":"The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a review of the current global status","volume":"13","author":"Bchetnia","year":"2020","journal-title":"Journal of infection and public health"},{"issue":"3","key":"10.1016\/j.jgr.2024.12.004_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105924","article-title":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges","volume":"55","author":"Lai","year":"2020","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"10.1016\/j.jgr.2024.12.004_bib131","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41392-020-00243-2","article-title":"COVID-19: immunopathogenesis and Immunotherapeutics","volume":"5","author":"Yang","year":"2020","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.jgr.2024.12.004_bib132","series-title":"Comparison of possible use in COVID-19 and influenza","first-page":"535","author":"Lee","year":"2021"},{"issue":"2","key":"10.1016\/j.jgr.2024.12.004_bib133","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jgr.2022.01.004","article-title":"Ginseng, a promising choice for SARS-COV-2: a mini review","volume":"46","author":"Ratan","year":"2022","journal-title":"Journal of ginseng research"},{"issue":"3","key":"10.1016\/j.jgr.2024.12.004_bib134","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jgr.2022.01.003","article-title":"Possibility as role of ginseng and ginsenosides on inhibiting the heart disease of COVID-19: a systematic review","volume":"46","author":"Hossain","year":"2022","journal-title":"Journal of Ginseng Research"},{"issue":"1","key":"10.1016\/j.jgr.2024.12.004_bib135","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jgr.2022.09.004","article-title":"Panax ginseng as a potential therapeutic for neurological disorders associated with COVID-19; toward targeting inflammasome","volume":"47","author":"Shin","year":"2023","journal-title":"Journal of Ginseng Research"},{"issue":"2","key":"10.1016\/j.jgr.2024.12.004_bib136","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jgr.2022.01.002","article-title":"COVID-19 and Panax ginseng: targeting platelet aggregation, thrombosis and the coagulation pathway","volume":"46","author":"Lee","year":"2022","journal-title":"Journal of Ginseng Research"},{"issue":"3","key":"10.1016\/j.jgr.2024.12.004_bib137","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jgr.2022.02.003","article-title":"Korean Red Ginseng, a regulator of NLRP3 inflammasome, in the COVID-19 pandemic","volume":"46","author":"Jung","year":"2022","journal-title":"Journal of Ginseng Research"},{"key":"10.1016\/j.jgr.2024.12.004_bib138","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105820","article-title":"Identification of natural compounds as SARS-CoV-2 entry inhibitors by molecular docking-based virtual screening with bio-layer interferometry","volume":"172","author":"Zhang","year":"2021","journal-title":"Pharmacol Res"},{"issue":"2","key":"10.1016\/j.jgr.2024.12.004_bib139","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jgr.2022.09.001","article-title":"In silico investigation of Panax ginseng lead compounds against COVID-19 associated platelet activation and thromboembolism","volume":"47","author":"Quah","year":"2023","journal-title":"Journal of Ginseng Research"},{"issue":"9","key":"10.1016\/j.jgr.2024.12.004_bib140","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e19341","article-title":"In silico and in vitro inhibition of host-based viral entry targets and cytokine storm in COVID-19 by ginsenoside compound K","volume":"9","author":"Boopathi","year":"2023","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.jgr.2024.12.004_bib141","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/s12906-022-03736-5","article-title":"Long-term evaluation of safety and biological effects of Korean Red Ginseng (Panax Ginseng): a long-term in vivo study","volume":"22","author":"Park","year":"2022","journal-title":"BMC Complementary Medicine and Therapies"},{"issue":"12","key":"10.1016\/j.jgr.2024.12.004_bib142","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1089\/acm.2015.0206","article-title":"Effects of complementary combination therapy of Korean red ginseng and antiviral agents in chronic hepatitis B","volume":"22","author":"Choi","year":"2016","journal-title":"J Alternative Compl Med"}],"container-title":["Journal of Ginseng Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1226845324001623?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1226845324001623?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T12:06:36Z","timestamp":1740053196000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1226845324001623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":142,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1226845324001623"],"URL":"https:\/\/doi.org\/10.1016\/j.jgr.2024.12.004","relation":{},"ISSN":["1226-8453"],"issn-type":[{"value":"1226-8453","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiviral potential of ginseng: Targeting human pathogenic viruses with compounds derived from ginseng","name":"articletitle","label":"Article Title"},{"value":"Journal of Ginseng Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgr.2024.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Korean Society of Ginseng. Publishing services by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}